Anas Alani

Anas Alani, MD is an Assistant Professor in both Medicine and Radiology at the School of Medicine, University of California, Los Angeles. His academic career spans cardiovascular medicine with a strong emphasis on advanced imaging techniques and coronary pathophysiology.

Dr. Alani's research interests focus on:

• Cardiovascular imaging using computed tomography
• Coronary artery disease and atherosclerosis
• Diabetes-related cardiovascular complications
• Valvular heart disease and interventions
• Cardiovascular risk assessment in special populations
• Extra-coronary calcification patterns

His scholarly work demonstrates expertise in applying advanced imaging modalities to understand cardiovascular pathophysiology and improve diagnostic accuracy. Dr. Alani has contributed significantly to the field of coronary plaque characterization, positive remodeling in smokers, and the application of CT angiography in various clinical scenarios including diabetes, HIV, and metabolic syndrome.

Dr. Alani's publication record shows consistent productivity since 2013, with 24 publications through 2024. His work frequently appears in high-impact cardiology and radiology journals including the Journal of the American College of Cardiology, American Journal of Cardiology, and JACC: Cardiovascular Interventions. His research demonstrates methodological rigor with extensive use of CT angiography, intravascular ultrasound, and other advanced imaging techniques to quantify coronary plaque characteristics.

Dr. Alani is currently serving as Principal Investigator for a clinical trial titled "Effect of Tirzepatide on progression of coronary atherosclerosis using MDCT" sponsored by Eli Lilly & Co. (2025-2026), indicating ongoing active research in diabetes and cardiovascular disease. His work frequently collaborates with Dr. Matthew Budoff and other cardiovascular imaging experts, contributing to multicenter studies including the DCCT/EDIC Research Group and Multicenter AIDS Cohort Study.